18:18 IST
NSE
Dividend
Sun Pharmaceutical Industries Dividend
Sun Pharma's board recommended a 500% final dividend for FY 2025-26. This move signals strong cash flows and a commitment to rewarding shareholders.
Sun Pharmaceutical Industries Ltd
- Share price
- ₹1,781.00
- Market cap
- ₹4,27,322 Cr
- Revenue (annual)
- ₹58,462 Cr
- Net profit (annual)
- ₹11,479 Cr
- P/E (TTM)
- 35.3×Sector 47.3×
- Promoter holding
- 54.48%+0.00% QoQ
- FII holding
- 14.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 9Annual General Meeting 8Financial Results 5Promoter Reclassification 4Other Announcement 4Management Change 4Merger & Restructuring 3Credit Rating 3Acquisition 3Legal & Regulatory 2Business Update 2Board Meeting Date 2Regulatory Approval 1Price Movement Clarification 1Dividend 1Board Meeting Outcome 1Annual Report 1
Time
1 announcement with these filters